Millions of deaths and ongoing illnesses caused by the COVID-19 pandemic have pr...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the N...
A University of Texas at Arlington engineering researcher is working on defenses...
As we age, it’s more important than ever to carefully maintain our health and we...
Swiss pharmaceutical firm Novartis said on Monday that it has purchased biotechn...
Late-stage study results from BridgeBio’s phase 3 trial of its heart disease dru...
Alnylam has made significant progress in combating Alzheimer’s disease using its...
It seems like pharmaceutical layoffs are in full flow as FibroGen and Boston Sci...
Sanofi and AstraZeneca have obtained approval from the US Food and Drug Administ...
The Phase II trial for Zynlonta and Rituxan in DLBCL patients was discontinued a...
Johnson & Johnson (J&J) has reported sales of $25.53bn in Q2 of 2023, indicating...
Biotechnology firm EpiBiologics has appointed Dr Ann Lee-Karlon as CEO, presiden...
The US FDA has granted approval for Daiichi Sankyo’s Vanflyta to treat adults wi...
The FDA grants SN Bioscience’s nano-therapy SNB-101 an orphan drug designation f...
Other forms of immunotherapy have progressed rapidly in recent years, but oncoly...
To reduce cash burn, the company has sold off its Asia Pacific operations, excep...
